Corporate Governance
The German Corporate Governance Code pursues the aim of making the rules applicable to corporate management and monitoring in Germany transparent for German and international investors. It aims to boost confidence in the business management of German companies. The aim is to focus more closely on the interests of shareholders. The German Corporate Governance Code is supposed to make German business management and the dual legal structure involving an Executive Board and a Supervisory Board more transparent. Detailed comments on the members of the Supervisory Board and auditors, their functions and their independence contribute to an open corporate policy.
Individual points of criticism are taken into consideration in the regulations and provisions of the Code. The statutory framework conditions are observed here but not all issues can be regulated in every particular through the Code. Rather, it constitutes a framework, which companies have to fill in.
-
Declaration on Corporate Governance
-
Notification of
voting rights -
Directors' Dealings
-
Executive and
Supervisory Board -
Independent auditors
-
Articles of Association
In our Declaration on Corporate Governance pursuant to section 289a of the HGB, we publish the Declaration of Conformity in accordance with section 161 of the German Stock Corporation Act, information on Corporate Governance practices and the functions of the Executive Board and Supervisory Board. Our focus here is concentrated on making our business management transparent and comprehensible.
Declaration of Conformity pursuant to §161 German Stock Corporation Act (AktG)
Pursuant to section 161 of the German Stock Corporation Act (AktG), the Executive and Supervisory Boards of listed companies are obliged to issue an annual statement on whether they have adhered to and will adhere to the recommendations of the German Corporate Governance Code. section 9 (1) c) ii) of Council Regulation (EC) on the Statute for a European Company (SE) No. 2157/2001 dated 8 October 2001 states that the management and supervisory bodies of an SE with registered offices in Germany are also obliged to issue a declaration pursuant to section 161 AktG. The German Corporate Government Code is published by the Federal Ministry of Justice in the official section of the electronic Federal Gazette (Bundesanzeiger) and is also available on, among other places, the website www.corporate-governance-code.de. It contains recommendations on corporate governance with regard to shareholders and the Annual General Meeting, Executive and Supervisory Boards, transparency, accounting and audit of the financial statements. If the listed stock company has not been in conformance with a recommendation or if it does not plan to be in conformance with a recommendation, Executive Board and Supervisory Board are obliged under the terms of section 161 AktG to declare this and give reasons in their annual declaration of conformity.
The German Corporate Governance Code was amended on 26 May 2010. The amended version was published in the Federal Gazette on 2 July 2010. The following declaration of conformity relates to the version of the German Corporate Governance Code dated 26 May 2010 for the period from 2 July 2010 and to the version of the Code dated 18 June 2009 for the period from the submission of the last declaration of conformity by the Executive Board and Supervisory Board in March 2010 until 2 July 2010. The Executive Board and Supervisory Board of Q-Cells SE declare that, with the following exceptions, the recommendations of the “Government Commission on the German Corporate Governance Code” have been and are being complied with:
- Divergent from point 3.8 of the Code, the Company took out D&O insurance for the Supervisory Board without a deductible. The Supervisory Board shares the view that the deductible in a D&O insurance policy is not an appropriate means of achieving the objectives of the Code. Such deductibles are generally insured against by the members of the Supervisory Boards, so that the actual function of the deductible is void and it is ultimately merely a question of the level of remuneration of the Supervisory Board. For this reason, a deductible is not the usual custom abroad.
For analogous reasons, the D&O insurance for the Executive Board initially did not include a deductible either. The Law on the Appropriateness of the Executive Board’s Remuneration (VorstAG) dated 31 July 2009 now provides for a compulsory deductible in D&O insurance for Executive Board members. The Company complied with the stipulations of section 93 (2) AktG in the version of the Law on the Appropriateness of the Executive Board’s Remuneration (VorstAG) dated 31 July 2009 and adjusted the D&O insurance for Executive Board members accordingly with effect from the expiry of the statutory transition period on 1 July 2010. The D&O insurance for Executive Board members now includes a deductible at the amount prescribed by law.
In deviation from Clause 4.2.3 of the Code, the remuneration of the Executive Board member Dr. Nedim Cen did not contain any variable components until the end of August 2010. Dr. Nedim Cen’s responsibilities initially focused on the implementation of the current restructuring measures. Against this background, Dr. Nedim Cen worked for the Company on the basis of a consultancy agreement concluded between Q-Cells SE and Alvarez & Marsal until the end of August 2010. The agreement of variable remuneration therefore does not seem to make sense. This situation changed with the extension of the appointment of Dr. Nedim Cen as a member of the Executive Board until 2015 and the conclusion of an Executive Board employment contract directly between Q-Cells SE and Dr. Nedim Cen as of 1 September 2010. The employment contract concluded with Dr. Nedim Cen also includes variable components.
The objectives for the composition of the Supervisory Board were formally determined in March 2011 (Clause 5.4.1 of the Code). The composition of the Supervisory Board is already taking into account the international activities of the company, potential conflicts of interest and diversity, particularly with regard to the participation of women, while paying attention to the specific situation of the Company.
|
Date
|
Document
|
Download
|
|---|---|---|
|
17.03.2011
|
-Declaration of Conformity 2011
|
|
|
24.03.2010
|
-Declaration of Conformity 2010
|
|
|
12.03.2009
|
-Declaration of Conformity 2009
|
|
|
13.03.2008
|
-Declaration of Conformity 2008
|
|
|
19.03.2007
|
-Declaration of Conformity 2007
|
|
|
31.08.2006
|
-Declaration of Conformity 2006
|
|
|
22.08.2005
|
-Declaration of Conformity 2005
|
Functions of Executive and Supervisory Board
The Executive Board and Supervisory Board have a close and trusting working relationship with the common goal of the sustained and long-term improvement of the Company value. While the Executive Board is responsible for the management of the Company, the Supervisory Board monitors the work of the Executive Board. Both functions are obliged to act in the interests of the shareholders who participate in the management of the company at the Annual General Meeting. The cooperation of all bodies is governed by the Articles of Association.
The Executive Board of Q-Cells SE manages the Company on its own behalf, develops the strategic approach of the Company and ensures its implementation. Here, its work is based equally on taking account of the interests of shareholders, its employees and other groups of people associated with the Company (stakeholders). It informs and advises the Supervisory Board regularly and promptly on issues of strategy and planning relevant to the enterprise as a whole and with regard to business development, the financial position, performance and business risks and discusses them with it.
The Supervisory Board’s remit includes the appointment of members of the Executive Board. It also monitors the Executive Board’s management and advises it on the same. In addition to the items listed in article 12 (3) of the Articles of Association, the Supervisory Board determined other transactions requiring the approval of the Supervisory Board. Adherence to compliant and efficient processes is guaranteed through Rules of Procedure developed in-house.
Various committees were established to ensure effective working methods: an Audit Committee, a Presidential Committee (previously: Remuneration Committee), a Strategy Committee and a Nomination Committee. The composition of the Supervisory Board of Q-Cells SE meets the requirements of an internationally focused company and the Supervisory Board has set an age limit, as envisaged in the GCG Code. In the composition of the Supervisory Board, attention was also paid to the fact that the members of the Supervisory Board reflect the diversity of the international business world without resulting in conflicts of interest with their other activities. Detailed information concerning the Supervisory Board and the cooperation between the Supervisory Board and the Executive Board can be found in the Report of the Supervisory Board.
Risk management
Q-Cells has a comprehensive risk management system to prevent and manage risk. For the Executive Board and Supervisory Board, responsibly handling risks affecting Q-Cells business activities is of utmost importance. Risk management reports directly to the Executive Board.
The main feature of the risk management system is the active involvement of Q-Cells employees who are actively responsible for managing risks. The aim of Q-'Cells’ risk management system is, through active identification, analysis and assessment as well as documentation and reporting, to avoid any threats to the Company’s existence, to make the existing risk situation transparent and consequently to secure the Company’s targets and future success and to safeguard and increase its value in the long term.
The function of the risk management system is to safeguard the Group’s successful strategic and operational focus by weighing up strategic and operational opportunities with the corresponding risks and using them as a basis for business decisions.
Disclosures on Corporate Governance Practices
CORPORATE SOCIAL RESPONSIBILITY:
RESPONSIBILITY FOR THE ENVIRONMENT
Socially responsible business management is becoming ever more important as an element of corporate policy. This element is not only the result of an astute corporate direction but it answers questions about the Company’s ethics. Brands and products that are launched at great expense are also to be boosted, above and beyond their characteristics, by a corporate philosophy that engenders trust.
Protection of the environment counts as a guiding theme for our day-to-day activities. For example, Q-Cells satisfies 100% of its daily electricity requirement at its German sites through green electricity. However, for us, sustainable enterprise goes far beyond our internal processes, materials used and relationships with suppliers. We are increasingly interested in the aspects of our purchases of relevance to the environment. In 2007, we started to analyse the lifecycle of individual preliminary products in context with the “burden” added within our production and to assess the resultant impact on the environment. In 2008, this was followed by the analysis of the lifecycles of additional products to provide us with information on the levers we can apply jointly with the manufacturers.
As part of sound business management, issues are raised, which relate to the ecological dimension of sustainability. To meet these ambitions of responsible business management, the new production plant in Malaysia was constructed in accordance with ecological and economic methods of construction. It is distinguished by low greenhouse gas emissions in addition to efficient cell production. The Code of Conduct is a material component in implementing sustainability in all value added chains. Code of Conduct
It defines the Group-wide principles and requirements for suppliers of goods and services with regard to their responsibility to mankind and their environment. Checking compliance with these principles is a component of audits of our suppliers. We have been carrying out this kind of assessments of our suppliers since 2005.
Recycling is an issue at the other end of the value added chain. While we are just at the outset of the development of photovoltaic systems, we are already concerned at present with the issue of recycling disused solar systems. Under the umbrella of the PV-Cycle organisation, to which 70 % of the European photovoltaic market belongs, members are developing a voluntary return and recycling system. We are actively involved in the design of the system and also in the public relations work needed to acquire more members.
RESPONSIBILITY FOR SOCIETY
Q-Cells’ international focus requires that we adapt to the various cultures in which we operate. Dealing appropriately with business partners and society in various regions is crucial to a company’s positive development. Meanwhile, Q-Cells would like the regions in which its sites are located to share in its innovations. We therefore support many projects to promote the use of solar energy. Development of regenerative energies is driven by expanding research, development and education. As the patron of an educational and environmental project in Africa, Q-Cells wishes to press ahead with the use of solar energy and improve the education system in these regions.
You can find further Q-Cells’ measures and projects relating to the topic of sustainability and social responsibility here: Corporate Responsibility
Code of ethics:
Here you can find our Code of Ethics as a download.
baSiC PrinCiPLeS fOr Our COnduCt
Each individual employee counts at Q-Cells. Together we are Q-Cells and act on the assumption that everyone will give their best. Close cooperation based on trust leads to shared success. We are respectful and considerate, and behave in an open, fair manner towards one another.
1.1 A constructive approach
At Q-Cells, we are convinced that it is worth our while to work together in a constructive, trusting manner on all levels. This is the way to achieve the best possible results. Being involved in a successful work project motivates people and increases their willingness to perform. If our partners derive benefit from our work, they will be enthusiastic about working together with us again in the future. We provide long-term prospects for our clients and thus achieve profitability for all those involved. We create values for our employees and our shareholders. More than anything, we also play a part in creating a world which is supplied with clean energy.
We encourage our employees’ initiative and their willingness to act. Achievement and dedication should be worth their while. As a basic rule, everyone must take responsibility for their own actions. At times, consequences are inevitable. Wherever people take action and make decisions, errors cannot be ruled out. It is essential to learn how to handle them. Recognizing errors in the present helps us to avoid them in the future. We encourage each and every person to admit to errors and address problems, as a problem which is not acknowledged may result in serious consequences.
In order to achieve success in our business, we also need to set ambitious goals and achieve them. At the same time, it must be pos¬sible to deal with any problems arising in an open, clear-cut way and find a solution. Unachievable or incorrectly established goals are no use to anyone. That is why we encourage all employees to point out in good time when it may not be possible to achieve targets. This is the only way to ensure that we have enough time and the opportunity to deal with difficulties and find solutions.
Our aim is to create a culture of communication where argument matters and where we can learn from one another. We should all make every effort to ensure we can set a good example.
1.2 Responsible corporate management
Q-Cells is a commercial enterprise focused on increasing its value on a sustained basis and on achieving its business goals.
We take responsibility for our environment. For us, the environment also includes people, society and future generations in addition to nature.
If we lead the field of advanced technology, we will be able to remain competitive and pursue our ambitious goals further. That is why we permanently strive for excellent results and set stringent quality requirements for our products and solutions. For us, progress, economic success and social responsibility go hand in hand.
1.3 Sustainability
We are conscious of the shortage of natural resources and of our social responsibility towards future generations. For us, sustainable development implies combining the preservation and protection of the environment with financial well-being and social justice.
We use the principle of sustainability to guide us in developing our products and processes and attach particular importance to social acceptance and mutual respect. We have become party to different international agreements in which generally accepted codes of behavior are laid out. We also expect our business partners to abide by these codes.
1.4 Human dignity, human rights and nondiscrimination
Our company is founded on mutual respect. At Q-Cells, all kinds of people work together in a constructive way. We respect the personal dignity of each individual and are committed to safeguarding human rights. In particular, we will not tolerate the exploitation of chil¬dren and young people due to child labor or forced labor of any type.
We treat each other with respect, and are loyal and fair towards one another. We do not tolerate any discrimination on the grounds of nationality, ethnic origins, culture, religion, skin color, sex, age, sexual identification, political orientation, or physical disability. Likewise, we do not tolerate any sexual harassment or other personal attacks on individuals within the company or with regard to our business partners.
We promote the professional and personal development of our employees and respond with a flexible approach to individual personal circumstances. Balancing work with family life is important for us and we expressly and actively support such an endeavor. Only em¬ployees who are happy will make every effort to find innovative, creative solutions. We cannot and do not want circumstances to be otherwise.
1.5 Management culture and managerial responsibility
An important prerequisite for compliance is exemplary conduct on the part of our management. Each individual manager acts as a role model and must behave as such. Good leadership involves ensuring awareness and promotion of correct, lawful behavior at all times, an ethical standard which managers should exemplify through their own conduct. In other words, the "tone at the top"1 must be right for the rest to follow.
We expect our managers to trust their employees. They should allow their employees as much personal responsibility and freedom as possible, while also offering them guidance. It is part of the managerial role to define and establish clear rules and processes, inform employees about them and check that they are complied with. We also consider transparent, honest communication a managerial responsibility. If a manager delegates individual tasks, they still bear responsibility for the behavior of their employees. Supervision is a managerial responsibility and cannot be delegated. Of course, employees cannot absolve themselves of their own responsibility either.
abOut thiS COde Of COnduCt
Acting with integrity is not only a duty for our employees, but is also an implicit requirement. We consider lawful conduct as the right way to act, expect such conduct from everybody and provide coherent, reasonable, appropriate measures to ensure that such integrity is in place. This Code of Conduct expresses our position. It defines basic standards for behavior, provides guidelines for decision making processes and forms the basis for formulating special rules and instructions.
As a basic principle, we as employees must be able to answer the following questions in the affirmative as a benchmark of our conduct:
• Do I act in Q-Cells’ interest?
• Do I act in accordance with this Code of Conduct?
• Can and do I wish to assume responsibility for my actions, both on a personal level and as a Q-Cells employee?
2.1 Area Of application
This Code of Conduct applies to all Q-Cells SE Group employees and those of its subsidiaries (hereinafter referred to as Q-Cells). This also includes CEOs, executive boards and supervisory boards.
2.2 Meaning Of compliance
Compliance refers to adherence to all statutory obligations and in-company rules. Our Code of Conduct fulfills many functions in this respect. It is designed to offer all employees guidance and support in their work as well reflect our compliance culture and promote its further development.
We need binding rules and processes to ensure that the legal risks of our business activities are kept under control and that the company is protected from any form of malpractice on the part of individuals. These rules and processes also enable us to assume our moral and legal responsibility to society at large. It is also our consistent aim to ensure that our employees’ core values are aligned with those of this Code of Conduct as far as possible.
Rules relevant to compliance are found in all areas of our company. It is not only a question of identifying those rules affecting your own area as important, but also of understanding the purpose of those relevant to other areas and abiding by them.
2.3 Compliance with the code Of conduct
Each Q-Cells employee is obliged to adhere to the Code of Conduct rules and has the right to expect others to comply throughout their dealings with him or her.
It is a manager’s duty to ensure that the employees under their supervision are familiar with this Code of Conduct. Checks are carried out on a regular basis during in-house audits to ensure compliance with the Code of Conduct rules. Any breaches will be reported to the Compliance Officer.
Each one of us influences Q-Cells’ image through their appearance and actions. We act on the assumption that everyone at Q-Cells will behave in an honest and correct manner in their dealings. However, we need to protect ourselves in case some people do not. If just one employee acts in an unlawful or inappropriate way, they can cause considerable damage to the company. For this reason, legal measures apply. Depending on the nature and seriousness of the infringement, breaches in the Code of Conduct can lead to consequences under employment law or even dismissal, claims for compensation and prosecution under administrative and criminal law.
2.4 International agreements
In addition to the laws and regulations in individual countries, there is also a series of agreements and recommendations from in-ternational organizations. They are primarily intended for the respective member states, but also serve as important guidelines for an international company. Q-Cells therefore attaches great importance to ensuring that its actions as a company conform with such guidelines. These particularly include:
• The UN’s General Declaration of Human Rights (1948) and the European Convention for the Protection of Human Rights and Fundamental Freedoms (1950).
• The International Labour Organization (ILO) Tripartite Declaration of Principles Concerning Multinational Enterprises and Social Policy (1977) and the ILO Declaration on Fundamental Principles and Rights at Work (1998).
• The OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions (1997).
• OECD Guidelines for Multinational Enterprises (2000)
• The "Agenda 21" action plan for sustainable development (final document for the UN Conference on the Environment and Development in Rio de Janeiro, 1992
• .UN Convention against Corruption (2005).
2.5 Different Law systems
Compliance is an international requirement. Compliance requires us as a company to conform to the respective statutory regula-tions in the different countries where we operate. As the Q-Cells head office is in Germany, German law takes precedence for the company. However, since we operate on an international level, we must comply with the respective national statutory regulations at each of our locations. In international transactions, each case needs to be studied carefully to determine which law system needs to be observed. In some cases, this may lead to a conflict between different regulations which both need to be observed. In the event of doubt, the Compliance Officer or Legal Department should be consulted on such matters.
Apart from compliance with laws, we always act in accordance with the customs of the country in question provided that they are compatible with the basic principles and rules of this code of conduct.
deaLingS with buSineSS PartnerS and third PartieS
3.1 Contractual basis
Trust is the basis of a successful business. We place trust in our business partners and we ourselves are trustworthy partners. As a basic principle, when working with business partners or other parties, we always base our partnership on written contracts or agree¬ments, so as to ensure that there is legal protection and clarity. Changeable parts of contracts such as product specifications, prices and supplementary agreements are also set out in writing without any exceptions. Such integral parts of contracts are checked in advance to verify their validity and to assess any possible associated risks. You can find further details in the Guidelines for Approv¬als and Signatures.
3.2 Competition Law, Antitrust Law And Foreign Trade Legislation
Fair competition
For Q-Cells, fair competition is a fundamental part of its business. It is the basis for healthy development and social benefit for the market. We convince our customers to buy our products based on their quality and their price-performance ratio. Each employee is obliged to comply with the rules of fair competition. These rules have been set out in numerous laws and regulations worldwide. Infringements may lead to stiff penalties and fines, not only for the company concerned but also for the people involved. There is also the threat of civil claims for damages. Everybody should keep in mind that any breaches in the law can damage our company’s image considerably.
Competition and antitrust law
We never enter into agreements with our competitors which are intended to distort or influence competition. It is important to remember that the decisive factor is not the external appearance of an agreement, but its intention. Even in the case of informal, supposedly private meetings with a competitor, the following topics must not be discussed under any circumstances:
• Prices, production output, capacities, distribution channels, profit margins
• Rigging of bids in response to invitations to tender
• Dividing up of customers, regions or production programs
• Non-competition
Not only explicit agreements but also mere exchange of information with competitors may represent an infringement of competition law. If you should ever be in doubt over whether a meeting may be held in the way that you intend and whether the topics you plan to discuss are permitted, the Compliance Officer or Legal Department should be consulted.
Trade controls
The import and export of goods, services, hardware, software and technology (even by email) are sometimes subject to complex regulations, such as:
• Economic sanctions, such as embargos
• Export control and foreign trade laws
• Import laws and regulations, including customs laws
Employees who deal with product imports and exports must be particularly careful to ensure that Q-Cells complies with all appli-cable rules and regulations.
3.3 Preventing and combating corruption
We compete on the market by presenting good arguments in favor of our products. We win contracts thanks to quality, benefits for our customers and a reasonable price. Corruption detracts from our arguments and those of all fair competitors. That’s why we sup¬port all national and international efforts aimed at preventing and eliminating corruption. Bribery and corruption will not be tolerated under any circumstances. Detailed rules regarding the issue of corruption can be found in our internal guidelines and instructions.
Corruption/bribery
A person is guilty of corruption if they use a position of power or trust to gain a benefit for themselves to which they have no legal right. A position of power may arise as a result of a role that a person plays in administration, justice, business or politics. The acquired benefit may be material, such as money or tangible assets, or immaterial, such as preferential treatment. The term "cor-ruption" also refers to the more closely defined terms bribery and bribability, acceptance of benefits and granting of an undue advantage.
By accepting or granting benefits in such a way without any legal basis, the parties involved violate moral standards or disregard their duties as an official or a professional. It makes no difference whether the benefit was offered or requested. Corruption in all its different forms is a criminal offence in Germany and most countries.
3.3.1 Offering and granting benefits – in particular invitations and gifts
It is strictly forbidden to offer, promise or grant benefits to decision makers in business partner companies to obtain contracts for Q-Cells in an unlawful way or influence the objectivity of business decisions.
We wish to maintain a good relationship with our business partners and clients. That is why it is permitted to accept invitations to lunches, dinners or events. It is crucial that such invitations are appropriate and not extravagant. As a basic principle, Q-Cells requires that a gift which is not moderate or appropriate, or even just appears not to be so, must be declined. Every country has different standards and laws which determine whether a gift is socially acceptable or not.
For this reason, detailed, country-specific information, maximum limits or guidance values and regulations should be requested from the Compliance Officer or the Compliance Representative in the respective country’s organization.
There is no objection to promotional gifts or other gifts for business partners provided their value does not exceed a reasonable amount. Gifts must not put the receiver in a position where they feel bound by obligation. A good benchmark for such cases is the "in-public test": would you tell others or speak about the gift in public without giving it a second thought? As a general rule, if you feel that no¬body should know about a particular gift, then it is not moderate or appropriate. As a basic principle, giving money and services as a gift is strictly prohibited. Reasonable invitations and gift for occasions such as birthdays or Christmas and other religious festivals are generally acceptable.
You should avoid even merely giving the impression that you expect a service in return. In this respect, gifts and invitations are pro¬hibited before and in connection with the signing of contracts, for example, since giving such a benefit may influence the receiver’s decision-making process in an unlawful way.
Working with public officials and government contracts
Particularly strict rules apply in the case of dealings with public officials. These include public servants and other employees in public administrations, other public institutions, public sector companies and international organizations as well as candidates for political office and official representatives and employees of a political party. Political parties are also public officials in this respect. The type of post which can be considered a public position varies greatly from country to country.
We bid for government contracts all around the world and we take great care not to influence the decision-making process of public officials in an unlawful or dishonest way. In doing so, we comply with all laws and regulations regarding public procurement. In this context, too, we act in a transparent, honest and lawful manner.
All Q-Cells employees are strictly forbidden to offer, promise or grant benefits to a public official in order to secure an official con¬tract or preference in a business transaction. Employees must also refrain from giving gifts and making invitations of minor value. You may be committing an offence in terms of granting an undue benefit. Exceptions in individual cases must be approved by the Compliance Office.
3.3.2 Requesting and accepting benefits – invitations, gifts and similar
The same principles apply to requesting and accepting benefits as offering and granting them. A Q-Cells employee must not try to use their position or role in the company to acquire a personal benefit. In particular, it is forbidden to request or accept benefits from business partners in order to give a business partner preferential treatment in a dishonest way.
As a basic principle, the same rules apply for receiving gifts as for giving them (see above). This includes all cases of acquiring ben¬efit for oneself and for people related to you. If gifts exceed a reasonable value, employees must decline them. If they greatly exceed such a value, employees are obliged to inform their superior or the Compliance Officer. Employees should always take great care when it comes to gifts. Accepting a gift may lead to a conflict of interest, even though intentions may be good, and may jeopardize our company’s reputation. In the event of doubt, the Compliance Officer should be contacted.
We maintain a good relationship with our business partners and clients. That is why it is permitted to accept invitations to lunches, dinners or events from time to time. This particularly applies to official occasions and holidays, or if you wish to celebrate a joint success. In doing so, it is essential take into account the maximum limits and regulations of the country in question. Full require-ments are stipulated in the corresponding internal guidelines.
Donations and sponsorship
At Q-Cells, donations and sponsorship agreements are controlled centrally in the Corporate Communications Department. Any other employees who are approached by third parties with regard to donations and sponsorship should forward such requests to this de¬partment. In general, the following applies:
Donations
Q-Cells can donate money or goods to educational und scientific concerns, to art and culture projects, for social purposes and to promote sports. In doing so, it must act in a transparent way and document who receives the donation and what the donation is used for. We must be able to account for donations in public at any time.
We do not give donations to individuals or profit-oriented organizations. Donations deposited in private bank accounts and donations which may damage Q-Cells’ image are prohibited. The receiver’s aims and Q-Cells’ corporate values must not be inconsistent with one another.
Political donations to individuals, parties or other organizations are not permitted.
Contributions to trade associations or membership fees for organizations which serve our business interests are not regarded as donations.
Sponsorships
Q-Cells may provide money or goods for an event organized by third parties as part of a sponsorship deal. In return, Q-Cells may ex¬ploit the event for promotional purposes. This may comprise the use of the Q-Cells logo or the mention of Q-Cells name in a speech. Free entrance tickets for the event, an event venue for Q-Cells’ use or other contractually agreed services may also be provided in return.
Sponsorship deals are agreed in a written contract, serve a serious, commercial purpose, must maintain an appropriate balance between outlay and return service and, like donations, require full transparency.
Consultants and agents
Q-Cells also uses consultants and agents, such as sales agents. Such persons may initiate, arrange and process business transac-tions on our behalf and receive commission or payment in return for their services. Sales agent activities include finding business opportunities, showing potential customers what Q-Cells is capable of, building up contacts and providing help in dealing with government authorities.
Consultants and agents can provide substantial support for our sales and marketing in international business operations. However, if they use illegal business practices, this also damages our reputation. We therefore only work with distribution partners who comply with all statutory regulations.
We take specific precautionary measures when entering into agreements with consultants and sales agents to prevent illegal busi-ness practices:
• We conclude a written contract with the consultant or agent before establishing a partnership.
• We check and document if and why a consultant or agent is needed.
• Before entering into the contract, checks are carried out regarding the consultant’s character.
• Payment or commissions may only be paid for clearly defined services and must be in proportion to the service provided.
• As a basic principle, public officials must not be engaged as distribution partners or business agents for government contracts.
• Payments may only be made to the contractual partner named in the agreement in the form of a bank transfer. This means that there are no cash payments or payments to third parties. Additional checks must be carried out by the Compliance Officer or Legal Department in the case of conspicuous foreign accounts, such as those in so-called tax havens.
Full details are stipulated in the corresponding internal guidelines.
3.4 Business relationships with suppliers
A modified extract from this Code of Conduct applies to suppliers. They are bound by a contract to comply with this version of the code. As a basic principle, we expect our partners to:
• Comply with all applicable laws
• Refrain from becoming involved in corruption
• Observe the human rights of their employees
• Comply with laws prohibiting child labor
• Assume responsibility for health and safety towards its members of staff
• Comply with relevant national laws and international standards regarding environmental protection
• Ensure that these values are also respected throughout their own supplier chain
LOyaLty tO Q-CeLLS – handLing COnfLiCtS Of intereSt
A conflict of interest occurs when an individual finds himself or herself in a situation where they must chose between two or more incompatible interests. Such a situation often arises if an employee acts in their own personal interest and in conflict with their interests in a professional capacity. Personal interest then prevents them from acting in the best interests of the company.
Conflicts of interest or loyalty have a negative effect on professional duties and damage the company. It is therefore important for Q-Cells employees to recognize any conflicts of interest which may arise in the context of their professional duties at an early stage and avoid them. A conflict may also occur if an employee’s close relative derives benefit or could derive benefit from the employee’s position. The same applies if an employee actively tries to acquire a benefit for a member of their family and uses their position in the company to do so.
An employee who needs to consider proposals submitted by tradesmen must make an unbiased decision free of any conflict of inter¬est. He or she is unable to do this if one of the bidders is carrying out work for him or her in a private capacity. There is a risk that the employee will feel an obligation towards the aforementioned bidder.
Acting in your own personal interest in the course of professional duties may also mean that you easily overstep boundaries and become involved in corruption.
4.1 Avoiding conflicts Of interest
All employees must ensure that they make business decisions in the best interests of the company. Any employees who find them-selves in a conflict of interest or in a situation where a conflict of interest may arise are therefore obligated to inform their superior of such circumstances. Transparency provides effective protection against the suspicion of a conflict of interest. In the event of doubt, employees may consult the Compliance Officer on such issues.
When making decisions regarding purchases, we base our decision exclusively on the interests of the company. Key objective criteria for decision-making processes are:
• Quality
• Technology
• Price
• Production requirements
• Logistics
You should avoid any conflict of interest or even merely giving the impression that such a conflict exists. As a basic principle, business contacts must not be used for private business transactions or the purchase of goods or services for personal use.
4.2 Competition with Q-cells
Q-Cells employees who also work for another company may also experience a conflict of interest. As a result, Q-Cells employees may not operate, manage or work for a company which is a competitor of Q-Cells. As a basic principle, employees may not be involved in any activities which are in competition with the business interests of the Q-Cells group.
4.3 Interests in third Party companies
Holding a stake in another company may also lead to a conflict of interest for the employee concerned. Therefore, the following restrictions apply regarding companies which are competitors or with which Q-Cells has a business relationship: no employee may be involved in the management of such a company or hold a direct or indirect stake in such a company. This does not apply to shareholdings which demonstrably have no influence over Q-Cells’ operations. Employees who hold or acquire a direct or indirect stake in a competitor’s company must disclose this interest to their human resources department or the Compliance Officer if such an interest allows them to exercise influence over the management of the company concerned. It can be generally assumed that such potential to exercise influence over management exists if the stake is in excess of 5% of the company’s total equity.
4.4 Secondary employment
Employees must inform their Human Resources Manager in advance of any intention to take up paid, secondary employment. Such employment requires prior written consent from the Human Resources Department to avoid any potential conflict of interest. The Human Resources Department responsible can provide further information on this aspect.
Q-Cells welcomes any opportunities for employees to take responsibilities. Therefore, we expressly support any social or political in¬volvement that our employees may have in associations, political parties or social institutions. Secondary employment and volunteer activities must be organized in such a way that they are fully compatible with contractual obligations to Q-Cells.
handLing COMPany PrOPerty
All company assets and resources such as machines, vehicles, equipment, computers, warehouse stock and office material are acquired to serve our company’s goals. Therefore, they may only be used for purposes related to company operations. We handle company resources in an economical and responsible way, while also taking care with expenses and financial resources.
It is inevitable that company property is consumed or is inadvertently damaged. Anyone who becomes aware of such a defect or shortage, whether they themselves are responsible or not, should ensure that the item is repaired or replaced, or inform the col-league responsible for such matters of the situation. The private use of company property is only permitted in cases expressly regulated in company guidelines. Anyone who would like to use company property for private purposes should speak to their superior. The approval process for such matters is regulated on a local basis. It should be noted that the user may be liable for any damage to company property occurring during private use, depending on the circumstances. This may prove to be expensive for the employee.
finanCe & aCCOunting
The four-eye principle applies to the signing of contracts, the approval of payments and all other relevant business transactions.
Four-eye principle
This is a special internal check procedure designed to prevent an employee involved in a transaction (the so-called first signatory) from taking important decisions or carrying out crucial activities on their own. The four-eye principle ensures that another person, independent of the first signatory, checks and signs or approves the process or document, thus guarding against errors and abuse of powers of authorization.
6.1 Documentation and financial reporting
Q-Cells Group companies must document and enter into account all business transactions in a full, proper and truthful manner using the correct systems and
• forward them to the relevant authorities or office as appropriate and in good time to ensure that they comply with statutory ac¬counting
• obligations and contractual obligations to report.
It is strictly forbidden to conceal losses or budget overspending, or manipulate accountancy figures. Such activity may result in criminal charges as well as other consequences.
All data, test certificates, and other written documents which are required for financial reporting and for compliance with statutory reporting requirements must be kept in a safe place where access is guaranteed at all times. Internal invoices such as claims for travel expenses are also subject to obligatory documentation requirements.
6.2 Processing Of payment transactions and combating money Laundering
As a basic principle, payment transactions are not effected in cash, but are handled through money transfers. Cash payments or other unusual payment methods may aid and abet illegal activities such as tax evasion, corruption, fraud, embezzlement, or money laundry (see below). We wish to avoid any association with such illegal activities when processing payments and therefore any un¬usual or suspicious payments must be reported to the Compliance Officer immediately.
Money Laundering
If "dirty money" from criminal activities is introduced into legal circulation, through cash payment, for example, this is referred to as money laundering. During this process, money is camouflaged, thus appearing to be from a legal source and the source or the real identity of the original owner is concealed as a result. Corruption is a major source of such "dirty money".
PrOteCtiOn and PaSSing On infOrMatiOn
7.1 Storage Of documents und data
There are statutory or official regulations which require us to store a large number of business documents beyond the period of time when they are actually in direct use. The applicable period for safekeeping varies from case to case and on occasions may be very long. However, it can be useful to store documents as documentary evidence even if there is no particular obligation to safeguard them, so that we are able to protect Q-Cells’ interests in the event of a product liability claim, for instance.
Each department is obliged to store the documents for which they are responsible. It must find out about the applicable storage periods and arrange suitable safekeeping. It must be possible to locate complete documents quickly in case they are needed. Each department will also ensure in cooperation with the IT Department that electronic data and documents are readable for the whole period of time when they are kept in storage. If staff leave or are relocated, or if departments are restructured, the handover of duties also includes the transfer of archived data and information into systems.
Documents and data which are no longer required because their storage period has expired should be destroyed as soon as possible. Confidentiality, data protection needs, and protection of intellectual property contained or recorded in documents must also be guaranteed at this stage. The only exception is when any documents are required for an ongoing lawsuit. In such cases, it is forbid¬den to destroy relevant documents, even when the statutory period for safekeeping has expired. Should such a case arise, contact the Compliance Representative, the Compliance Officer or the Legal Department responsible for advice.
7.2 Security Of it systems
IT security involves the protection and safeguarding of data, information, resources in the information system and employees. It also expressly includes compliance with external and internal regulations and standards. At Q-Cells, the following criteria have been defined as the general aims of information security and, in particular, IT security.
• Confidentiality of information
• Availability of information and resources
• Integrity of information and resources
• Binding character (nonrepudiation) of transactions
Security policy requirements are achieved by introducing and implementing generally accepted and proven measures which are matched to the particular risks and technical features of the information and systems concerned.
We protect our IT systems from unauthorized access to prevent confidential information from being disclosed or data from being lost or destroyed. We use passwords and encryption methods for this purpose. The issuing of access authorizations is regulated in the corresponding IT guidelines.
Stable IT systems make a considerable contribution towards a company’s success. This is why nobody except expressly authorized employees may test compatibility in systems or install new hardware and software.
As a basic principle, email and Internet may only be used for authorized activities. Full requirements are stipulated in the IT guide¬lines.
7.3 Protectable data – intellectual property, data protection, secrecy and protection Of third Party rights
Our knowledge and our skills form the basis of our business success. Intellectual ownership of industrial property rights, such as patents, utility patents and brands, embodiments, developments, designs, inventions and copyrights therefore play an exceptional role in our company.
While developing products, technologies and production processes, we gain specialist knowledge which may secure us a competitive advantage over other suppliers in our market segment. This basis for innovation and technological lead must be protected. When appropriate, a patent is filed for inventions and they receive special protection as a result.
We respect the rights of third parties to their intellectual property. In the event that we wish to use them, we apply for a license wherever possible and carefully comply with license conditions and validity periods.
If an employee leaves our company, documents, data, trial product samples and similar all remain in our possession. We also ensure compliance with post-contractual obligations.
Specific rules which have been established for visitors and employees of external companies serve to protect our intellectual property among other things. This includes items such as limited access authorizations or the need to obtain a special permit for photography.
Data protection and protection Of third Party rights
We are aware of the risks which electronic data processing and electronic communication entail with regard to data security and the protection of privacy. We comply with all corresponding statutory regulations in this respect. Personal data may only be acquired, processed or used if there are clearly defined, legitimate reasons for doing so. It must be ensured that personal data is safely stored at all times and is only forwarded to other persons if the necessary precautionary measures have been taken. It must be clear to the parties concerned how and for what purpose their personal data is being used. We are obliged to ensure that they are able to exercise their right to information, rectification, objection, suspension and deletion of their data without any hindrance.
The processing of personal data by other companies, i.e. outsourced data processing, is subject to special rules. These also apply within the group of companies. The data protection officer should be consulted starting at the planning stage.
Confidentiality and protection Of business secrets
Business information should be treated as confidential. All employees must implement suitable precautionary measures to ensure that:
• No business information is unintentionally or inadvertently disclosed
• No unauthorized persons are able to access company documents or data storage devices
• No confidential company matters are discussed in public when unauthorized persons may be able to listen
All employees are obligated to maintain secrecy with reference to internal confidential or protected information. This also applies to information which should not be disclosed to the public. Within the company, sensitive information should only be passed on if it is required for business purposes. The obligation to maintain secrecy continues to apply even after employment relationships have ceased. The same applies to information concerning suppliers, customers, employees, representatives, consultants and other third parties. There is also an obligation to handle such information responsibly and protect it in accordance with statutory and contractual requirements.
It is forbidden to acquire secrets of a third party and use them without authorization.
7.4 Directors’ dealings and legislation regarding insider trading
As a listed company, Q-Cells is obligated to the capital market and its investors and is subject to stock and capital market law regu¬lations. This particularly applies to the rules on the disclosure of capital market information and the monitoring of insider trading. Insider information refers to specific information regarding a listed company which
• is not yet in the public domain and
• which, if it were made public, would having a significant influence on the stock exchange price or market price of the shares is¬sued by the company concerned. This is deemed to be the case if a knowledgeable investor takes such information into account when making a decision to invest.
Such information includes:
• Unpublished financial figures, such as earnings performance
• Major business transactions, such as planned takeovers or the signing of agreements
• The status of major projects
Anyone who has access to such information is referred to as an insider. The use of insider information in the trading of shares or financial instruments and the unauthorized disclosure of insider information are unlawful and are subject to prosecution under civil and criminal law. For this reason, particular care should always be taken when handling insider information.
Anyone who has access to insider information regarding Q-Cells or another listed company must not trade in shares or financial instruments of such companies. He or she is also not permitted to have another person trade on their behalf or recommend that a third party trade in such shares or instruments. If they do so, they are committing an offence by disclosing insider information to a third person without authorization.
It may be difficult to judge whether you are an insider yourself or whether information can be identified as insider information in individual cases. In the event of doubt or any questions, the Compliance Officer or Compliance Representative will be glad to help at your location.
Persons who carry out executive functions at Q-Cells and those who have a close relationship with such persons must inform Q-Cells and the German Federal Office for Financial Service Supervision (German: BaFin) in writing of any transactions involving Q-Cells shares and related instruments (so-called directors’ dealings) worth over 5,000 euros during any given calendar year within five working days of the transaction. Checking and assessing directors’ dealings may prove difficult, but the consequences of infringe¬ments in the law are considerable. In the event of even the slightest doubt, the Compliance Officer should be contacted without delay.
Information which, if it were made public, would have a significant influence on Q-Cells’ market value is published as a so-called ad-hoc announcement, an action which is required under the German Securities Trading Act. Publishing such information creates fair conditions – in this case, the same conditions – for all investors on the stock market. At Q-Cells, an expert team carries out checks to establish whether an ad-hoc announcement is required or not.
7.5 Corporate communications and public relations
A positive perception of Q-Cells in the public eye plays a considerable role in ensuring the success of our company. We take very good care of our corporate image. This applies to all written, verbal and electronic forms, such as advertising material, presentations or talks.
Our carefully cultivated corporate image is consistent with our overall corporate culture. We take an open, honest, respectful and credible approach both internally and externally. This also applies to all our communications – face-to-face meetings, telephone calls and written statements on paper and in emails.
Each employee is responsible for ensuring a good style of communication is maintained. Q-Cells’ image is not only perceived through its corporate communications, but also as a result of each individual contact with the outside world. Every employee repre¬sents the whole company in this respect.
The media is highly influential, in both a positive and negative sense. That is why how we appear in the media is particularly impor-tant for our corporate image. Q-Cells has established departments which are responsible for all contact with the media. Any type of contact with the media must be agreed in advance with these departments and expressly approved by them. Our employees must not make any statements or give out information regarding our company without prior consent.
Please contact the Corporate Communications for more detailed information.
Appearances in public
We particularly welcome it when our employees are involved in public offices on a municipal or national level. However, if this involvement is connected with Q-Cells activities in any way, the employee needs to obtain prior consent from the Corporate Com-munications Department.
As private individuals, Q-Cells employees, of course, have the right to freely express their opinion. In doing so, they must, of course, also treat any information which they have obtained as a result of their employment as confidential. When expressing opinions in private, they must ensure that they do not refer to their role or their duties at Q-Cells. It is in the company’s interest and each indi¬vidual employee’s obligation to ensure that their behavior in public does not damage Q-Cells’ reputation.
the envirOnMent, Safety and heaLth in the wOrkPLaCe
8.1 Environmental protection and technical safety
For Q-Cells, environmental protection is not only a statutory obligation, but also one of the key reasons for its existence. Through our business activities, we seek to promote a clean, sustainable source of energy supply. In this way, we make a contribution to combating climate change and take responsibility for the environment and for future generations. At Q-Cells, products, investments, manufacturing processes and work conditions are based on the principles of sustainability.
Q-Cells complies with all applicable environmental regulations. We obtain all necessary permits and licenses in good time and ensure that any requirements or necessary conditions are met. We wish to cooperate with supervisory authorities effectively on a basis of mutual trust.
We encourage our employees to actively assist in improving all existing environmental protection measures. Whenever employees point out areas where energy can be saved or resources in general can be conserved, we will try to take suitable measures wherever possible. Environmental protection is the duty and objective of the company and each individual employee.
8.2 Health and safety in the workplace
We take our responsibility for the health and safety of our employees in the workplace very seriously. This applies to all departments in our company. At the same time, employees themselves are also obliged to take care at all times. Anyone who plans ahead and assesses the risks for themselves and their colleagues makes a considerable contribution to ensuring that work conditions are safer.
Health and safety in the workplace are regulated by a large number of laws, regulations and internal instructions. These must be complied with. Each employee is fully informed about existing regulations and any changes to them on a regular basis.
Our COMPLianCe ManageMent
9.
Each employee bears responsibility for ensuring compliance. Our managers are also required to create the organizational structures for compliance in their departments and to introduce suitable processes. Our compliance management fulfills the following tasks:
• Risk assessment for key processes with regard to compliance issues
• Advisory for the executive board, departments and international subsidiaries when implementing solutions
• Implementation of training courses and provision of training documents
• Development of secondary processes and provision of central systems for compliance issues
• Investigation of incidents and response to possible infringements
At Q-Cells, these tasks are performed by the Chief Compliance Officer and the Compliance Officer. Compliance Representatives are appointed for individual departments, locations and subsidiaries as required.
The Compliance Officer acts in the capacity of contact person for all employees, can answer any questions on compliance and also serves in the capacity of advisor for issues related to the Code of Conduct. The Compliance Officer receives all incoming information and tips regarding compliance and follows them up with due care. All incoming information is treated as strictly confidential. The Chief Compliance Officer reports to the Executive Board about the current status of the company’s compliance policies and procedures on a regular basis. Questions regarding this Code of Conduct will arise on a continuous basis. Different contact persons are available within the company to discuss such matters. Depending on their question, employees may contact the following at any time:
• The Compliance Officer
• Their respective Compliance Representative
• The Legal Department
• Their respective superior
deaLing with COMPLaintS
10.
Employees may consult their supervisor with regard to any concerns or complaints related to this code of conduct; depending on the circumstances or the issue, they may also contact the Compliance Officer or their local Compliance Representative. Such issues may include questions regarding individual points or may be notification of possible infringements.
Q-Cells has a fair, open and respectful culture of criticism and conflict management. If an employee raises a concern or makes a complaint in good faith, they must not be put at a disadvantage as a result.
Secondary
Investor Relations Contact

The direct link for all Investor Relations enquiries.
All dates

Don't miss a date or trade fair ever again!
Reports

Here you can order or download our reports or browse online.
Ecological trading

Q-Cells systems are 100% environmentally friendly. We promote environmental awareness during production.
|
Date
|
Document
|
Download
|
|---|---|---|
|
20.01.2012
|
-GOOD ENERGIES, COFRA, FAIRMARK, FONTANA, ARIOSO, CONSTANTER, AVENIA
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
16.12.2011
|
-GOOD ENERGIES, COFRA, FAIRMARK, FONTANA, ARIOSO, CONSTANTER
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
16.12.2011
|
-GOOD ENERGIES, COFRA, FAIRMARK, FONTANA, ARIOSO, CONSTANTER
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
22.11.2011
|
-GOOD ENERGIES, AVENIA, COFRA
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
22.11.2011
|
-GOOD ENERGIES, AVENIA, COFRA
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
18.11.2011
|
-Taube Hodson Stonex Partners LLP, London, Great Britain
Announcement pursuant to section 21 para.1 WpHG (Securities Trading Act) |
|
|
14.11.2011
|
-Taube Hodson Stonex Partners LLP, London, Great Britain
Announcement pursuant to section 21 para.1 WpHG (Securities Trading Act) |
|
|
03.06.2011
|
-Baillie Gifford & Co, Edinburgh, Great Britain
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
11.03.2011
|
-Taube Hodson Stonex Partners LLP, London, Great Britain
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
28.01.2011
|
-Citigroup Inc., Wilmington, Delaware, USA
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
17.12.2010
|
-Citigroup Inc., Wilmington, Delaware, USA
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
08.12.2010
|
-Citigroup Inc., Wilmington, Delaware, USA
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
26.11.2010
|
-Citigroup Inc., Wilmington, Delaware, USA
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
23.11.2010
|
-Citigroup Inc., Wilmington, Delaware, USA
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
18.11.2010
|
-Citigroup Inc., Wilmington, Delaware, USA
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
18.11.2010
|
-GOOD ENERGIES, AVENIA, COFRA
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
15.11.2010
|
-Citigroup Inc., Washington, USA
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
05.11.2010
|
-DWS Investment GmbH, Frankfurt/Main, Germany
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
28.10.2010
|
-The Goldman Sachs Group, Inc., New York, USA The Goldman, Sachs & Co. L.L.C., Wilmington, USA Goldman, Sachs & Co., New York, USA
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
22.10.2010
|
-Baillie Gifford & Co, Edinburgh, Grossbritannien Baillie Gifford Overseas Limited, Edinburgh, Great Britain
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
22.10.2010
|
-GOOD ENERGIES, AVENIA, COFRA
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
21.10.2010
|
-UniCredit Bank AG, Munich, Germany UniCredit S.p.A., Rome, Italy
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
20.10.2010
|
-The Goldman Sachs Group, Inc., New York, USA
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
20.10.2010
|
-Citigroup Inc., Washington, USA
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
13.10.2010
|
-DWS Investment GmbH, Frankfurt/Main, Germany
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
08.10.2010
|
-GOOD ENERGIES, AVENIA, COFRA
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
17.09.2010
|
-Baillie Gifford Overseas Limited, Edinburgh, Great Britain
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
09.04.2010
|
-Baillie Gifford Overseas Limited, Edinburgh, Great Britain
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
02.02.2010
|
-BlackRock Investment Management (UK) Limited, BlackRock Group Limited, BlackRock International Holdings, Inc., BlackRock Advisors Holdings, Inc., BlackRock Financial Management, Inc., BlackRock Holdco 2, Inc.
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
08.01.2010
|
-Good Energies Investments 3 (Luxembourg) S.à r.l., Good Energies Investments 4 (Luxembourg) S.à r.l. and COFRA Treasury Services S.A
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
06.10.2009
|
-Taube Hodson Stonex Partners LLP. London, Great Britain
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
25.09.2009
|
-Taube Hodson Stonex Partners LLP. London, Great Britain
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
03.09.2009
|
-Taube Hodson Stonex Partners LLP. London, Großbritanien
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
21.08.2009
|
-Good Energies Investments (Luxembourg) S.à r.l. and Good Energies Investments 3 (Luxembourg) S.à r.l.
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
03.04.2009
|
-Fidelity International, Tadworth, Great Britain, in the name and on behalf of FMR LLC, Boston, USA
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
|
|
31.03.2009
|
-Announcement of Fidelity International, Tadworth, Great Britain, in the name and on behalf of FMR LLC, Boston, USA
Announcement pursuant to sec. 21 para. 1 WpHG (Securities Trading Act) |
Secondary
Investor Relations Contact

The direct link for all Investor Relations enquiries.
All dates

Don't miss a date or trade fair ever again!
Reports

Here you can order or download our reports or browse online.
Ecological trading

Q-Cells systems are 100% environmentally friendly. We promote environmental awareness during production.
|
Date
|
Document
|
Download
|
|---|---|---|
|
26.11.2008
|
-Publication of Directors' Dealings pursuant to § 15a WpHG: Dr. Hartmut Schüning
Announcement |
|
|
15.09.2008
|
-Publication of Directors' Dealings pursuant to § 15a WpHG: Quercus GmbH
Announcement |
|
|
23.05.2008
|
-Publication of Directors' Dealings pursuant to § 15a WpHG: Hartmut Schüning
Announcement |
|
|
29.11.2007
|
-Publication of Directors' Dealings pursuant to § 15a WpHG: Constanze Schmidt
Announcement |
|
|
16.07.2007
|
-Publication of Directors' Dealings pursuant to § 15a WpHG: TVVG Solarbeteiligungen GmbH, Pluto Solarbeteiligungen GmbH
Announcement |
|
|
02.07.2007
|
-Publication of Directors' Dealings pursuant to § 15a WpHG: Thomas Schmidt
Announcement |
|
|
17.04.2007
|
-Publication of Directors' Dealings pursuant to § 15a WpHG: TVVG Solarbeteiligungen GmbH, Pluto Solarbeteiligungen GmbH
Announcement |
|
|
13.04.2007
|
-Publication of Directors' Dealings pursuant to § 15a WpHG: Milner Solarbeteiligungen GmbH
Announcement |
|
|
10.04.2007
|
-Publication of Directors' Dealings pursuant to § 15a WpHG: Thomas Schmidt
Announcement |
|
|
02.04.2007
|
-Publication of Directors' Dealings pursuant to § 15a WpHG: Thomas Schmidt
Announcement |
|
|
14.02.2007
|
-Publication of Directors' Dealings pursuant to § 15a WpHG: Frauke Vogler
Announcement |
|
|
13.02.2007
|
-Publication of Directors' Dealings pursuant to § 15a WpHG: Milner Solarbeteiligungen GmbH, TVVG Solarbeteiligungen GmbH, Pluto Solarbeteiligungen GmbH
Announcement |
|
|
16.06.2006
|
-Publication of Directors' Dealings pursuant to § 15a WpHG: TVVG Solarbeteiligungen GmbH, Pluto Solarbeteiligungen GmbH
Announcement |
|
|
26.04.2006
|
-Publication of Directors' Dealings pursuant to § 15a WpHG: Ströher Finanzholding AG
Announcement |
|
|
25.01.2006
|
-Publication of Directors' Dealings pursuant to § 15a WpHG: TVVG Solarbeteiligungen GmbH, Pluto Solarbeteiligungen GmbH
Announcement |
|
|
13.10.2005
|
-Publication of Directors' Dealings pursuant to § 15a WpHG: Frauke Vogler
Announcement |
|
|
11.10.2005
|
-Publication of Directors' Dealings pursuant to § 15a WpHG: Milner Solarbeteiligungen GmbH, Reiner Lemoine, TVVG Solarbeteiligungen GmbH, Pluto Solarbeteiligungen GmbH
Announcement |
|
|
22.09.2005
|
-Publication of Directors' Dealings pursuant to § 15a WpHG: Ströher Finanzholding AG, TVVG GmbH, capitalnetworks.de GmbH, Pluto 2001 GmbH
Announcement |
Secondary
Investor Relations Contact

The direct link for all Investor Relations enquiries.
All dates

Don't miss a date or trade fair ever again!
Reports

Here you can order or download our reports or browse online.
Ecological trading

Q-Cells systems are 100% environmentally friendly. We promote environmental awareness during production.
Executive Board
A dynamic company with experienced directors: solar know-how and professional management go hand in hand.
The Members of the Executive Board will concentrate on a rigorously pursuing the implemented strategy of Q-Cells to develop new products and speed up the internationalization of our business model. We are in a strong position to carry on our success story and play a leading role in the global solar energy markets, which are continuing to grow at a very high speed.

Dr. Nedim Cen (*1965)
In March 2010 Nedim Cen was appointed to the position of CEO of Q-Cells SE, having initially joined the Executive Board of the company in June 2009. In this role he is responsible for Corporate Strategy, Legal & Compliance, Corporate Communications and Human Resources within Q-Cells SE. Furthermore he heads Marketing & Sales. In this role he assumes responsibility for Sales Products & Systems, Product Management, Marketing, Central Customer Service, Project & Service Management.
Nedim Cen has gathered almost two decades of experience in management consultancy, investment banking and operative management. In the course of his career Nedim Cen has worked for Alvarez & Marsal, McKinsey & Company, Goldman Sachs, Dresdner Bank and Credit Suisse and has also served as CFO at KION Group. He holds a master's degree in mechanical engineering (Dipl.-Ing.) and business administration (Dipl.-Kfm) and was awarded a PhD. (Dr. oec.) from the University of St. Gallen in Switzerland.

DR. ANDREAS VON ZITZEWITZ (*1960)
In August 2011 Andreas von Zitzewitz was appointed to the position of COO of Q-Cells SE. In that function he is responsible for Production, Research & Development, Purchasing, Logistics and Quality with regards to crystalline solar cells, solar modules and solar systems as well as CIGS thin-film modules of the subsidiary Solibro. Furthermore he heads Marketing & Sales. In this role he assumes responsibility for Sales Products & Systems, Product Management, Marketing, Central Customer Service, Project & Service Management.
The 51-year old electrical engineer, who graduated with a doctorate, has extensive management experience in the photovoltaic and semiconductor industries. Previously he was an Executive Board member of the solar company Conergy, prior to that at the semiconductor producer Infineon Technologies and at Siemens.
Supervisory Board
The supervisory board at Q-Cells SE is more than a control committee. It is consultant and partner at the same time.
The Board’s members have made a long-term commitment to the well being of Q-Cells SE and support the firm as internationally experienced experts. Six of the nine Supervisory Board members are elected by the Annual General Meeting, and three by the employees.
Prof. Dr. h.c. Karlheinz Hornung
Chairman of the Supervisory Board since 06/2010, term ends 2014
Prof. Dr. Eicke Weber
Member of the Supervisory Board since 04/2011, term ends 2014
Director of the Fraunhofer Institute for Solar Energy Systems ISE, Freiburg
Prof. Jörg Menno Harms
Member of Supervisory Board since 06/2009, term ends 2014
Managing Partner of Menno Harms GmbH International Management Service, Stuttgart
Frauke Vogler
Member of the Supervisory Board since 2005, term ends 2014
Lawyer and Tax Advisor, Partner at Vogler Roessink Chalupnik, Berlin
Helmut Gierse
Member of the Supervisory Board since 03/2010, term ends 2014,
Management Consultant, Nürnberg
Marcel Berghoff
Member of the Supervisory Board since 2009, term ends 2014
Employee representative
Position in the company: Employee Product Management
Constanze Schmidt
Member of the Supervisory Board since 2005, term ends 2014
Employee representative
Position in the company: Employee Human Resources
Uwe Schmorl
Member of the Supervisory Board since 2005, term ends 2014
Employee representative
Position in the company: Head of Works Council
Secondary
Investor Relations Contact

The direct link for all Investor Relations enquiries.
All dates

Don't miss a date or trade fair ever again!
Reports

Here you can order or download our reports or browse online.
Ecological trading

Q-Cells systems are 100% environmentally friendly. We promote environmental awareness during production.
Independent auditor
Consistent with the resolution passed at the Annual General Meeting on 24 June 2010, KPMG AG Wirtschaftsprüfungsgesellschaft, Leipzig, was appointed by the Supervisory Board to perform the audit of the single-entity financial statements and the management report of Q-Cells SE (individual financial statement) as well as the consolidated financial statements and the Group management report as of 31 December 2010. The individual financial statement was compiled according to German Commercial Code Standards (HGB), the consolidated financial statement in accordance with Section 315a of the German Commercial Code (HGB) on the basis of the International Financial Reporting Standards (IFRS), as applicable in the EU. The auditor conducted the audit in accordance with German generally accepted standards for the audit of financial statements promulgated by the Institut der Wirtschaftsprüfer (IDW) of the consolidated financial statements in accordance with International Standards on Auditing (ISA).
Both financial statements were given an unqualified audit certificate by the auditor on 16 March 2011.
Secondary
Investor Relations Contact

The direct link for all Investor Relations enquiries.
All dates

Don't miss a date or trade fair ever again!
Reports

Here you can order or download our reports or browse online.
Ecological trading

Q-Cells systems are 100% environmentally friendly. We promote environmental awareness during production.
Articles of Association
Please find the Articles of Association of Q-Cells SE for downloading (convenience translation). Last revised: 23 December 2011
|
Date
|
Document
|
Download
|
|---|---|---|
|
23.12.2011
|
-Articles of Association
|
Secondary
Investor Relations Contact

The direct link for all Investor Relations enquiries.
All dates

Don't miss a date or trade fair ever again!
Reports

Here you can order or download our reports or browse online.
Ecological trading

Q-Cells systems are 100% environmentally friendly. We promote environmental awareness during production.








































